Moreover, several Sirt1 inhibitors and compounds which suppress sirt1 expressions, included EX527, 15d-PGJ2, MHY2245 and Gerberoside were performed to treat ovarian cancer in vivo [154,157]. The gene discussed is SIRT1; the disease is ovarian carcinoma.